175 related articles for article (PubMed ID: 32927080)
1. Bronchoalveolar lavage differential cell count on prognostic assessment of patients with stable or acute interstitial lung disease: A retrospective real-life study.
Salonen J; Lampela H; Keskitalo E; Vähänikkilä H; Purokivi M; Kaarteenaho R
Clin Immunol; 2020 Nov; 220():108594. PubMed ID: 32927080
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of the bronchoalveolar lavage in interstitial lung diseases.
Efared B; Ebang-Atsame G; Rabiou S; Diarra AS; Tahiri L; Hammas N; Smahi M; Amara B; Benjelloun MC; Serraj M; Chbani L; El Fatemi H
J Negat Results Biomed; 2017 Mar; 16(1):4. PubMed ID: 28245857
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease.
Ba C; Jiang C; Wang H; Shi X; Jin J; Fang Q
Ther Adv Respir Dis; 2024; 18():17534666241250332. PubMed ID: 38757948
[TBL] [Abstract][Full Text] [Related]
5. Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease.
Kim Y; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS
Tohoku J Exp Med; 2018 Nov; 246(3):147-153. PubMed ID: 30405002
[TBL] [Abstract][Full Text] [Related]
6. [Comparative analysis of bronchoalveolar lavages in interstitial lung diseases].
Song KS; Heo WB; Won DI
Korean J Lab Med; 2007 Jun; 27(3):221-7. PubMed ID: 18094580
[TBL] [Abstract][Full Text] [Related]
7. Induced sputum compared to bronchoalveolar lavage for evaluating patients with sarcoidosis and non-granulomatous interstitial lung disease.
Fireman E; Topilsky I; Greif J; Lerman Y; Schwarz Y; Man A; Topilsky M
Respir Med; 1999 Nov; 93(11):827-34. PubMed ID: 10603633
[TBL] [Abstract][Full Text] [Related]
8. Bronchoalveolar lavage cellular patterns in monoclonal antibody-induced lung disease.
Gupta S; Smith P; Twigg Iii HL; Hage CA
Respiration; 2014; 88(3):185-9. PubMed ID: 24942974
[TBL] [Abstract][Full Text] [Related]
9. BAL in the diagnosis of smoking-related interstitial lung diseases: review of literature and analysis of our experience.
Domagała-Kulawik J
Diagn Cytopathol; 2008 Dec; 36(12):909-15. PubMed ID: 18855907
[TBL] [Abstract][Full Text] [Related]
10. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I
Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
[TBL] [Abstract][Full Text] [Related]
11. Bronchoalveolar lavage total cell count in interstitial lung diseases--does it matter?
Domagała-Kulawik J; Skirecki T; Maskey-Warzechowska M; Grubek-Jaworska H; Chazan R
Inflammation; 2012 Jun; 35(3):803-9. PubMed ID: 21882075
[TBL] [Abstract][Full Text] [Related]
12. Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature.
Kowal-Bielecka O; Kowal K; Highland KB; Silver RM
Semin Arthritis Rheum; 2010 Aug; 40(1):73-88. PubMed ID: 19152959
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of CD30 as a marker for th2 lymphocytes in bronchoalveolar lavage in interstitial lung diseases.
Petkova D; Xaubet A; Picado C; Filella X; Agusti C; Luburich P; Rodriguez-Roisin R
Respir Med; 2000 Apr; 94(4):345-9. PubMed ID: 10845432
[TBL] [Abstract][Full Text] [Related]
14. Bronchoalveolar Lavage Fluid Reflects a T
Friedmann D; Unger S; Keller B; Rakhmanov M; Goldacker S; Zissel G; Frye BC; Schupp JC; Prasse A; Warnatz K
Front Immunol; 2020; 11():616832. PubMed ID: 33613543
[TBL] [Abstract][Full Text] [Related]
15. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of NK cell percentages in bronchoalveolar lavage from patients with different fibrotic interstitial lung diseases.
Bergantini L; d'Alessandro M; Cameli P; Otranto A; Finco T; Curatola G; Sestini P; Bargagli E
Clin Immunol; 2021 Sep; 230():108827. PubMed ID: 34428741
[TBL] [Abstract][Full Text] [Related]
17. Differences in lymphocyte profile between BAL fluid and human lung tissue from patients with interstitial lung disease.
Fujimori F; Shimizu T; Takada T; Narita J; Suzuki E; Gejyo F
Br J Biomed Sci; 2008; 65(2):63-7. PubMed ID: 19055106
[TBL] [Abstract][Full Text] [Related]
18. Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease.
De Santis M; Bosello SL; Peluso G; Pinnelli M; Alivernini S; Zizzo G; Bocci M; Capacci A; La Torre G; Mannocci A; Pagliari G; Varone F; Pistelli R; Danza FM; Ferraccioli G
Clin Respir J; 2012 Jan; 6(1):9-17. PubMed ID: 21801327
[TBL] [Abstract][Full Text] [Related]
19. Exacerbation of bleomycin-induced injury by lipopolysaccharide in mice: establishment of a mouse model for acute exacerbation of interstitial lung diseases.
Kimura T; Nojiri T; Hosoda H; Shintani Y; Inoue M; Miyazato M; Okumura M; Kangawa K
Eur J Cardiothorac Surg; 2015 Oct; 48(4):e85-91. PubMed ID: 26224340
[TBL] [Abstract][Full Text] [Related]
20. Bronchoalveolar lavage cell pattern from healthy human lung.
Heron M; Grutters JC; ten Dam-Molenkamp KM; Hijdra D; van Heugten-Roeling A; Claessen AM; Ruven HJ; van den Bosch JM; van Velzen-Blad H
Clin Exp Immunol; 2012 Mar; 167(3):523-31. PubMed ID: 22288596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
